Around-the-clock performances presented using cutting-edge holograms intended to show hundreds of thousands of visitors ...

Shares of Protagonist Therapeutics PTGX have gained nearly 7% over the past week. The upside came after the company announced ...

The name Harrison is mentioned in the conversation, but the male speaker is not Harrison; he remains unidentified. CSP Nwode and Inspector Harrison Akama were both associated with the Rapid Response ...

Johnson & Johnson’s Icotyde receives US FDA approval for first-line systemic treatment of plaque psoriasis with a targeted oral peptide: Spring House, Pennsylvania Friday, March ...

J&J wins FDA nod for Icotyde, a once-daily oral psoriasis pill, boosting its new drugs portfolio and challenging injectable treatments in a key market.

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...

Reps. Tom Gann, RInola, and Kevin West, RMoore, on Wednesday filed a brief asking the Oklahoma Supreme Court to overturn $98 million in rate increases for Oklahoma Natural Gas (ONG) well as $1.77 ...

Find all the best things to do in Pittsburgh this weekend, from NatureFest to the Pittsburgh Fringe Festival to the Japanese Film Festival.

Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...

Johnson & Johnson (JNJ) on Wednesday announced that the U.S. Food and Drug Administration (FDA) approved Icotyde, a once-daily pill developed with Protagonist Therapeutics (PTGX), as a treatment for ...

The Delhi High Court has stayed trial court proceedings against Bina Modi and Lalit Bhasin, who were summoned in an assault ...